INN name:
|
Tazemetostat
|
|||||||||||||||
Lab codes:
|
E-7438, EPZ-6438
|
|||||||||||||||
Chemical name:
|
N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-5-[ethyl(oxan-4-yl)amino]-4-methyl-4'-[(morpholin-4-yl)methyl][1,1'-biphenyl]-3-carboxamide
|
|||||||||||||||
Molecular formula:
|
C34H44N4O4
|
|||||||||||||||
Chemical Structure:
|
 |
|||||||||||||||
CAS Registry Number:
|
1403254-99-8
|
|||||||||||||||
Originator:
|
Epizyme
|
|||||||||||||||
Class:
|
Antineoplastic
|
|||||||||||||||
Mechanism of Action:
|
EZH2 enzyme
inhibitors
|
|||||||||||||||
WHO ATC code:
|
L01X-X
|
|||||||||||||||
EPhMRA code:
|
L1X9
|
|||||||||||||||
Clinical Trials:
|
||||||||||||||||
Thursday 17 September 2015
Tazemetostat
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment